Related Experiment Video
Updated: May 5, 2026

Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors
Published on: September 24, 2014
Clinico-Demographic Profile of Paediatric Patients with Primary Intracranial Tumours in South India
Nitin Joseph1, Ravikiran Sr2, Prithu A R Sagar3
1Department of Community Medicine, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka India.
Insights
Pediatric central nervous system cancers, particularly intracranial tumors, present diagnostic challenges due to non-specific symptoms. This study highlights medulloblastoma as the most common type in children, with vomiting being the most frequent symptom and Temozolomide the primary treatment.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Clinical Research
Background:
- Central and peripheral nervous system cancers are the second most common cancers in children (0-14 years).
- Diagnosing pediatric intracranial tumors is challenging due to non-specific clinical presentations.
- Understanding the socio-demographic profile, clinical features, and management of these tumors is crucial.
Purpose of the Study:
- To investigate the socio-demographic characteristics of pediatric patients with intracranial tumors.
- To identify the common clinical features and presenting symptoms of these tumors.
- To analyze the management practices and treatment outcomes for pediatric intracranial tumors.
Main Methods:
- A cross-sectional, medical record-based study was conducted.
- Data were collected from 31 pediatric patients (<18 years) diagnosed with primary intracranial tumors.
- A semi-structured proforma was used to record socio-demographic data, clinical features, tumor characteristics, and management.
Main Results:
- The median age at diagnosis was 7 years, with a majority of patients being male (54.8%).
- Medulloblastoma was the most frequent tumor type (38.7%), predominantly in the infratentorial region (58.1%).
- Vomiting (58.1%) was the most common symptom, and most tumors were Stage III/IV (64.5%). Chemotherapy was used in 74.2% of patients, with Temozolomide being the most common drug.
Conclusions:
- Male gender and medulloblastoma are common in pediatric intracranial tumors.
- Advanced tumor stages (III/IV) and vomiting are prevalent clinical findings.
- Chemotherapy, particularly Temozolomide, is a primary treatment modality for these pediatric cancers.
Abstract:
The central and peripheral nervous system cancers are the second most common cancers among the paediatric population (0-14 years). The non-specific symptoms seen in its clinical presentation make the diagnosis of these tumours extremely challenging among children compared to adults. This research study was therefore done to study the socio-demographic profile, clinical features, and management practices among paediatric patients with intracranial tumours. This was a cross-sectional medical record-based study done among 31 children aged < 18 years diagnosed with primary intracranial tumours. Data were recorded using a semi-structured proforma. The median age at diagnosis of tumours among the patients was 7(4, 15) years. Majority of them were males 17(54.8%). Medulloblastoma was the common tumour 12(38.7%). 18(58.1%) tumours originated from the infratentorial region. The most common infratentorial tumour was medulloblastoma, while the most common supratentorial tumour was meningioma. The most common site of involvement was the brainstem 11(35.5%). Majority of the tumours were presently in Stage III/IV 20(64.5%). The most common symptom was vomiting 18(58.1%). 23(74.2%) patients were managed using chemotherapy and among them the most used drug was Temozolomide 7(30.4%). Medulloblastoma was present more among patients who were diagnosed at the age ≤ 5 years (p = 0.022). Tumours involving the cerebellum were more among females (p = 0.0118). Headache was present more among patients who were diagnosed with tumours at the age > 5 years compared to the age ≤ 5 years (p = 0.0119). From the findings of this study, it can be concluded that majority of the patients were males. Medulloblastoma was the most common tumour. Close to two-third of the tumours were in Stage III/IV. The most common symptom reported was vomiting. The most used drug for treatment was Temozolomide.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology

